2023
DOI: 10.1111/cup.14414
|View full text |Cite
|
Sign up to set email alerts
|

Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics

Abstract: Background Trichorhinophalangeal syndrome type 1 (TPRS1) expression has been found to be highly sensitive and specific for breast carcinomas. The frequency of TRPS1 expression in cutaneous neoplasms such as mammary Paget disease (MPD) and extramammary PD (EMPD) is currently unknown. We assessed the utility of TRPS1 immunohistochemistry (IHC) in the evaluation of MPD, EMPD, and their histopathologic mimics, squamous cell carcinoma in situ (SCCIS) and melanoma in situ (MIS). Methods Twenty‐four MPDs, 19 EMPDs, 1… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

3
24
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 18 publications
(28 citation statements)
references
References 20 publications
3
24
1
Order By: Relevance
“…The results in this study are similar to those found in another recent study which evaluated TRPS1 staining in primary mammary Paget disease, EMPD (involving inguinal/groin, peri‐anal, axilla and trunk), squamous cell carcinoma in situ and melanoma in situ 15 . In this study, all the mammary Paget disease cases were TRPS1 immunoreactive, whereas only 68% (13 of 19) of EMPD cases were reportedly positive.…”
Section: Discussionsupporting
confidence: 90%
See 2 more Smart Citations
“…The results in this study are similar to those found in another recent study which evaluated TRPS1 staining in primary mammary Paget disease, EMPD (involving inguinal/groin, peri‐anal, axilla and trunk), squamous cell carcinoma in situ and melanoma in situ 15 . In this study, all the mammary Paget disease cases were TRPS1 immunoreactive, whereas only 68% (13 of 19) of EMPD cases were reportedly positive.…”
Section: Discussionsupporting
confidence: 90%
“…In this study, all the mammary Paget disease cases were TRPS1 immunoreactive, whereas only 68% (13 of 19) of EMPD cases were reportedly positive. Although these results appear lower than are found in the current study, it should be noted that five of the EMPD cases involving the inguinal/groin areas were from patients with known histories of colorectal or prostatic adenocarcinoma and may represent secondary EMPD; 15 based on the current study, these cases would be expected to be TRPS1‐negative. This recently published study also reports TRPS1 expression in 92% (12 of 13) of squamous cell carcinoma in situ cases; however, squamous cell carcinoma in situ and EMPD of the vulva rarely have significant morphological overlap due to full‐thickness atypia in the former.…”
Section: Discussioncontrasting
confidence: 88%
See 1 more Smart Citation
“…Regarding sweat gland tumors, primary EMPD was frequently TRPS1+, which is consistent with a previous report. 23 This may be because primary EMPD is thought to originate from anogenital mammary-like glands, which are TRPS1+. Studies have also shown that primary EMPD has similarities with breast cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Although the normal epidermis was TRPS1À, some cases of Bowen disease and actinic keratosis were TRPS1+, which is consistent with a previous report. 23 Since epidermal keratinocytes in the embryonal stage were TRPS1+, neoplastic keratinocytes in Bowen disease and actinic keratosis may revert to the embryonic stage due to tumorigenesis. However, there remains a contradiction since one case of invasive squamous cell carcinoma was TRPS1+.…”
Section: Discussionmentioning
confidence: 99%